Details of the Drug

General Information of Drug (ID: DMPO5IC)

• Drug Name: Interleukin-12 gene therapy

Indication

Disease Entry	ICD 11	Status	REF
Cutaneous T-cell lymphoma	2B01	Phase 2	[1]
Melanoma	2C30	Phase 2	[1]
Merkel cell carcinoma	2C34	Phase 2	[1]

• Cross-matching ID: TTD ID: D0U3AL
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] Clinical pipeline report, company report or official report of OncoSec Medical.